Bio Path Holdings Inc (BPTH) Financials
$0.02
As on 02-Sep-2026 15:13EDT
Market cap
$2 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.9
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cost of Revenue
|
--
|
--
|
0.18
|
0.18
|
0.16
|
0.15
|
|||||
|
Gross Profit
|
--
|
--
|
-0.18
|
-0.18
|
-0.16
|
-0.15
|
|||||
|
Operating Expenses
|
10.92
|
11.99
|
15.84
|
13.90
|
10.44
|
10.91
|
|||||
|
Operating Profit (EBIT)
|
-10.92
|
-11.99
|
-15.84
|
-13.90
|
-10.44
|
-10.91
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
0.03
|
|||||
|
Profit before Tax
|
-11.18
|
-9.89
|
-16.08
|
-13.87
|
-10.44
|
-10.88
|
|||||
|
Provision for Tax
|
--
|
--
|
--
|
-0.03
|
0.00
|
-0.03
|
|||||
|
Profit after Tax (Net Income)
|
-11.18
|
-9.89
|
-16.08
|
-13.84
|
-10.44
|
-10.86
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-10.44
|
-10.88
|
Liabilities ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-8.01
|
0.15
|
0.44
|
14.17
|
25.46
|
15.07
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.01
|
0.43
|
0.87
|
0.11
|
0.15
|
0.24
|
|||||
|
Current Liabilities
|
8.68
|
3.30
|
1.91
|
1.68
|
0.96
|
1.17
|
|||||
|
Total Liabilities
|
8.68
|
3.88
|
3.22
|
15.97
|
26.57
|
16.48
|
Assets ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
0.03
|
0.11
|
0.18
|
0.36
|
0.43
|
0.52
|
|||||
|
Current Assets
|
0.66
|
3.78
|
3.04
|
15.62
|
26.14
|
15.96
|
|||||
|
Total Assets
|
9.37
|
3.88
|
3.22
|
15.97
|
26.57
|
16.48
|
|||||
|
Total Debt*
|
--
|
--
|
0.11
|
0.22
|
0.24
|
0.33
|
|||||
|
Net Current Assets
|
-8.02
|
0.48
|
1.14
|
13.93
|
25.18
|
14.79
|
Cashflow ($ Mln) |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-10.58
|
-11.54
|
-15.10
|
-9.92
|
-10.96
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
--
|
-0.07
|
-0.07
|
|||||
|
Cash from Financing Activities
|
--
|
10.70
|
2.20
|
1.73
|
20.01
|
4.29
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
-6.67
|
Financials Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
-26.02
|
-38.65
|
-1.55
|
-2.82
|
|||||
|
Cash EPS ($)
|
--
|
--
|
-25.72
|
-38.15
|
-1.53
|
-2.78
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
0.71
|
39.59
|
3.79
|
3.92
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
-18.67
|
-42.19
|
-1.47
|
-2.85
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
-18.67
|
-42.25
|
-1.49
|
-2.85
|
Profitability Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-2,794.92
|
-215.10
|
-69.02
|
-50.80
|
-58.84
|
|||||
|
ROE (%)
|
--
|
-3,325.71
|
-220.02
|
-69.82
|
-51.51
|
-60.05
|
|||||
|
ROA (%)
|
-142.28
|
-278.59
|
-167.56
|
-65.05
|
-48.50
|
-55.48
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
-41,753.85
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
-14.24
|
-32.84
|
4.06
|
-25.18
|
|||||
|
Net Profit Growth (%)
|
-6.33
|
38.46
|
-16.21
|
-32.56
|
3.86
|
-27.64
|
|||||
|
EPS Growth (%)
|
--
|
--
|
0.33
|
-23.90
|
0.45
|
0.12
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
-0.02
|
-0.04
|
-2.43
|
-1.24
|
|||||
|
Price / Book Value
|
1.90
|
--
|
0.64
|
0.04
|
1.00
|
0.89
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
0.03
|
--
|
0.04
|
0.70
|
-0.18
|
0.00
|
|||||
|
Close Price ($)
|
--
|
1.16
|
9.20
|
30.20
|
75.40
|
70.00
|
|||||
|
High Price ($)
|
--
|
11.96
|
47.00
|
89.57
|
486.80
|
169.80
|
|||||
|
Low Price ($)
|
--
|
0.59
|
6.40
|
25.46
|
69.97
|
58.41
|
|||||
|
Market Cap ($ Cr)
|
1.51
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
0.26
|
0.02
|
0.01
|
0.02
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
0.23
|
0.02
|
0.01
|
0.01
|
|||||
|
Current Ratio
|
0.08
|
1.15
|
1.60
|
9.27
|
27.29
|
13.65
|
|||||
|
Quick Ratio
|
0.08
|
--
|
1.60
|
9.27
|
27.29
|
13.65
|
|||||
|
Interest Coverage
|
-64.75
|
--
|
--
|
-420.24
|
-3,480.00
|
--
|
Operating Efficiency Ratios |
TTM | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
4.33
|
4.22
|
2.04
|
2.48
|
|||||
|
Payable days
|
--
|
--
|
1,153.21
|
793.08
|
233.67
|
708.73
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|